• Publications
  • Influence
A New Rabies Vaccine Based on a Recombinant Orf Virus (Parapoxvirus) Expressing the Rabies Virus Glycoprotein
ABSTRACT The present study describes the generation of a new Orf virus (ORFV) recombinant, D1701-V-RabG, expressing the rabies virus (RABV) glycoprotein that is correctly presented on the surface ofExpand
  • 38
  • 3
  • PDF
Efficacy and safety of a feline immunodeficiency virus vaccine.
Fel-O-Vax FIV is an inactivated virus vaccine designed as an aid in the prevention of infection of cats, 8 weeks or older, by feline immunodeficiency virus (FIV). It contains two genetically distinctExpand
  • 23
  • 1
Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge
The duration of immunity of the dual-subtype feline immunodeficiency virus (FIV) vaccine, Fel-O-Vax FIV, for protection against subtype-B FIV was assessed in this study. Vaccinated cats along withExpand
  • 12
  • 1
Vaccination with an inactivated canine influenza H3N2 virus vaccine is safe and elicits an immune response in cats
Objectives The aim of this study was to evaluate safety and seroconversion when an inactivated H3N2 canine influenza virus (CIV) vaccine was administered to cats. Methods Twenty 7–8-week-oldExpand
  • 1